Transfer to Manufacture
Engineering and management creating a seamless transition from prototype to mass production for rapid launch
- Manufacturing process development
- Global supplier selection & management
- Cost of goods estimation & reduction
- Assembly & test design and automation
- Pilot manufacture under ISO 13485 and ISO 9001
- Manufacturing scale up
- Root cause analysis
CDP is an end-to-end innovation partner – a business optimized for breakthrough innovation. But end-to-end also means our process is streamlined: from the very beginning, we know where we’re headed. This pays off in a concrete way when it comes to one of the trickiest points in the development process: transferring the finished product to manufacturing.
We embed manufacturing engineering principles early on, ensuring ideal design for manufacture. As the design shapes up, we develop the appropriate manufacturing processes, supply chains, and automation solutions in parallel. Our ISO 13485 certification includes short-run manufacturing, enabling us to manufacture pre-production devices for extended testing, market, or clinical trials. We provide our clients with much more than the product IP: we make sure you have complete manufacturing information, so you have the flexibility to source the most competitive supply chains.
For clients who have already made development progress, we can help with manufacturing challenges through analyzing and solving problems and building supply chains and assembly and inspection systems. At CDP, we don’t just help clients to realize breakthrough products; we support them every step of the way.
Groundbreaking sustainability project addresses plastic waste
We’re proud to announce our work with Pulpex. A truly groundbreaking sustainability project addressing plastic waste, one of the most pressing challenges of our era.
Pulpex is a patented, first-of-its-kind pulp packaging innovation. Renewable, recyclable and biodegradable, Pulpex enables brands to completely rethink their packaging proposition. Chris Houghton and Wade Tipton describe our collaboration.
We manufacture Class II and III medical devices – mechanical and electronic, durable and consumable – for our global clients. So, we understand the barriers they face getting their product from design to manufacture for clinical trials.
Breaking the Mould: Digital tooling to reduce time to market
Getting new products to market efficiently is crucial to maximising your return on investment.
“Efficient and reliable manufacture is a prerequisite for profitable innovation. Our capability in both regulated and consumer products will shorten time to market and reduce launch costs.”